YU137186A - Process for obtaining cephalosporinic salts - Google Patents

Process for obtaining cephalosporinic salts

Info

Publication number
YU137186A
YU137186A YU01371/86A YU137186A YU137186A YU 137186 A YU137186 A YU 137186A YU 01371/86 A YU01371/86 A YU 01371/86A YU 137186 A YU137186 A YU 137186A YU 137186 A YU137186 A YU 137186A
Authority
YU
Yugoslavia
Prior art keywords
cephalosporinic
salts
obtaining
obtaining cephalosporinic
cephalosporinic salts
Prior art date
Application number
YU01371/86A
Other versions
YU45793B (en
Inventor
M A Kaplan
T W Hudyma
R A Lipper
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU137186A publication Critical patent/YU137186A/en
Publication of YU45793B publication Critical patent/YU45793B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
YU137186A 1985-08-05 1986-07-31 PROCESS FOR PREPARATION OF STABLE CRYSTAL ADDITIONAL SALTS OF 7- (ALPHA- (2-AMINOTHIAZOLA-4-YL) -ALPHA- (Z) -METHOXYIMINO ACETAMIDO / -3- / (1-METHYL-1-PYROLIDINO) -METHYL / -3- CEFEM-CARBOXYLATES WITH ACIDS, AS WELL AS PREPARATIONS CONTAINING THEM YU45793B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (2)

Publication Number Publication Date
YU137186A true YU137186A (en) 1987-12-31
YU45793B YU45793B (en) 1992-07-20

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
YU137186A YU45793B (en) 1985-08-05 1986-07-31 PROCESS FOR PREPARATION OF STABLE CRYSTAL ADDITIONAL SALTS OF 7- (ALPHA- (2-AMINOTHIAZOLA-4-YL) -ALPHA- (Z) -METHOXYIMINO ACETAMIDO / -3- / (1-METHYL-1-PYROLIDINO) -METHYL / -3- CEFEM-CARBOXYLATES WITH ACIDS, AS WELL AS PREPARATIONS CONTAINING THEM

Country Status (34)

Country Link
JP (1) JPH0615548B2 (en)
KR (1) KR930003121B1 (en)
AR (1) AR243894A1 (en)
AT (1) AT390957B (en)
AU (1) AU597262B2 (en)
BE (1) BE905219A (en)
CA (1) CA1284994C (en)
CH (1) CH675581A5 (en)
CS (2) CS276849B6 (en)
CY (1) CY1614A (en)
DD (2) DD254941A5 (en)
DE (1) DE3626375A1 (en)
DK (1) DK162053C (en)
EG (1) EG18003A (en)
ES (1) ES2002112A6 (en)
FI (1) FI84484C (en)
FR (1) FR2585705B1 (en)
GB (1) GB2179936B (en)
GR (1) GR862055B (en)
HK (1) HK99691A (en)
HU (1) HU196602B (en)
IE (1) IE59222B1 (en)
IL (1) IL79608A (en)
IT (1) IT1197067B (en)
LU (2) LU86540A1 (en)
MY (1) MY102212A (en)
NL (1) NL8601991A (en)
OA (1) OA08672A (en)
PT (1) PT83134B (en)
SE (1) SE469633B (en)
SG (1) SG79791G (en)
SU (1) SU1516013A3 (en)
YU (1) YU45793B (en)
ZA (1) ZA865842B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
JPH02101081A (en) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd Crystalline dihydrochloride of cephalosporin derivative and production thereof
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
DE602004011685T2 (en) 2003-12-23 2009-02-05 Sandoz Gmbh PROCESS FOR PREPARING INTERMEDIATE PRODUCTS FOR USE IN THE CEFALOSPORIN SYNTHESIS
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (en) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmaceutical preparation containing an antiviral dihydroquinazoline derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (en) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING CEPHALOSPORINES
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
SE8603308D0 (en) 1986-08-04
CS276717B6 (en) 1992-08-12
IE59222B1 (en) 1994-01-26
KR930003121B1 (en) 1993-04-19
SE8603308L (en) 1987-02-06
FR2585705B1 (en) 1989-01-13
DE3626375A1 (en) 1987-02-12
AU597262B2 (en) 1990-05-31
FR2585705A1 (en) 1987-02-06
JPH0615548B2 (en) 1994-03-02
IT8621409A1 (en) 1988-02-04
ZA865842B (en) 1987-04-29
DK162053C (en) 1992-02-10
DD254941A5 (en) 1988-03-16
FI84484B (en) 1991-08-30
IL79608A0 (en) 1986-11-30
AT390957B (en) 1990-07-25
YU45793B (en) 1992-07-20
HU196602B (en) 1988-12-28
FI84484C (en) 1991-12-10
PT83134B (en) 1989-07-31
GB2179936B (en) 1989-04-26
CA1284994C (en) 1991-06-18
DD268395A5 (en) 1989-05-31
IL79608A (en) 1991-07-18
GB8618989D0 (en) 1986-09-17
GR862055B (en) 1986-12-24
BE905219A (en) 1987-02-04
IE862078L (en) 1987-02-05
FI863155A0 (en) 1986-08-01
IT1197067B (en) 1988-11-25
FI863155A (en) 1987-02-06
SG79791G (en) 1991-11-15
JPS62103090A (en) 1987-05-13
DK162053B (en) 1991-09-09
CH675581A5 (en) 1990-10-15
OA08672A (en) 1989-03-31
IT8621409A0 (en) 1986-08-04
PT83134A (en) 1986-09-01
SU1516013A3 (en) 1989-10-15
CS276849B6 (en) 1992-08-12
SE469633B (en) 1993-08-09
AR243894A1 (en) 1993-09-30
LU88574I2 (en) 1995-03-01
AU6069486A (en) 1987-02-12
ES2002112A6 (en) 1988-07-16
DK371886A (en) 1987-02-06
GB2179936A (en) 1987-03-18
HK99691A (en) 1991-12-13
CY1614A (en) 1992-07-10
MY102212A (en) 1992-05-15
NL8601991A (en) 1987-03-02
DK371886D0 (en) 1986-08-04
HUT41802A (en) 1987-05-28
KR880002530A (en) 1988-05-09
EG18003A (en) 1991-08-30
ATA211086A (en) 1990-01-15
LU86540A1 (en) 1987-03-06

Similar Documents

Publication Publication Date Title
YU154986A (en) Process for obtaining bis-phosphitic compounds
YU44294B (en) Process for obtaining new antihypertenzic compounds
YU116787A (en) Process for obtaining imidazochynolinic derivatives
YU183586A (en) Process for obtaining chynoline derivatives
PT82062A (en) Process for preparing pyridinylimidazolidinone compounds
YU99386A (en) Process for obtaining new thienopyridones
HUT42441A (en) Process for preparing indolyl- and indazolyl-carboxamide derivatives
EP0199997A3 (en) Process for preparing diaryl-pentaerythritol
YU202686A (en) Process for obtaining hynolone
YU45469B (en) Process for obtaining imidazolylalkylguanidinic derivatives
YU137186A (en) Process for obtaining cephalosporinic salts
GR861004B (en) Process for preparing fluorized benzyltriazol compounds
PT83293B (en) Process for preparing dihidropyridine-2-hydroxyamines useful asmedicaments
PT83154A (en) Process for preparing quinolizinesulphonamides
ZA863454B (en) Process for preparing benzothiazolesulphenamides
HUT42766A (en) Process for preparing n-sulfamyl-3-(2-guanidino-thiazolyl-4-methyl-thio)-propionamidine
YU218086A (en) Process for preparing herbicidically effective imidazolynones
GR862769B (en) Method for preparing a-hydroxycarbonyl compounds
YU100886A (en) Process for obtaining 2-bromine-alpha-ergocriptine
HUT43022A (en) Process for preparing monochloro-pinacolone
PT82643A (en) Process for preparing substituted hexanydro arylquinolizines
HUT42769A (en) Process for preparing pyridazodiazepines
HUT43039A (en) Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
HUT40795A (en) Process for preparing fluoro-alkane compounds
GB2171096B (en) Process for preparing pyrone-3-carboxamide compounds